Paper Title
EVALUATION OF ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY OF ARGYREIA NERVOSA LEAF EXTRACTS
Article Identifiers
: Authors
Keywords
Argyreia Nervosa, Carrageenan, Plant extracts, Tail flick, Anti-Inflammatory, Analgesic
Abstract
Herbal therapy has been increasingly popular recently, signalling a "Return to Nature" from modern medication. The use of medicinal plants as a rich source of therapeutic substances for the treatment of sickness and other afflictions has been recognised for millennia and is highly regarded around the world. Nature has given us a very varied collection of plants that are grown wild around our nation in a wide variety of settings. Since ancient times, it has been popular in India to treat specific illnesses with various components of various medicinal plants. Common medicinal plant Argyreia nervosa is utilised in a number of ethno-medical formulations. It has historically been utilised as an antibacterial, antifungal, analgesic, anti-inflammatory, etc. substance. The anti-inflammatory efficacy of the leaf from Argyreia nervosa was examined in the current study using both an aqueous extract and a methanol extract. Aqueous and alcoholic leaf extracts of Argyreia Nervosa, 400 mg/kg body weight, shown considerable analgesic and anti-inflammatory action in the current investigation. However, at a dose of 200 mg/kg body weight, the same extracts showed little analgesic and anti-inflammatory efficacy. In conclusion, the presence of flavonoids and steroids in both aqueous and alcoholic extracts may be the cause of the analgesic and anti-inflammatory effects.
Downloads
How To Cite (APA)
SUNIL KUMAR B, SHIVARAJ GOUDA, SHUBHAM MANE, AKASH BIRADAR, & SHIVANI S (May-2023). EVALUATION OF ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY OF ARGYREIA NERVOSA LEAF EXTRACTS. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(5), a692-a698. https://ijnrd.org/papers/IJNRD2305087.pdf
Issue
Volume 8 Issue 5, May-2023
Pages : a692-a698
Other Publication Details
Paper Reg. ID: IJNRD_193774
Published Paper Id: IJNRD2305087
Downloads: 000122253
Research Area: Other
Author Type: Indian Author
Country: Bangalore, karnataka, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2305087.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2305087
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.
For more details, refer to the official notice: UGC Public Notice
Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: December 2025
Current Issue: Volume 10 | Issue 12 | December 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Dec-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
Approval, Licenses and Indexing: More Details
